Orally administered sesamin reduced the infiltrating mast cell count in the lesion relative to the that in untreated AD group (Fig. 7E), and reduced serum IgE, which activates degranulation of mast cells during the allergic response and is a hallmark of AD (Fig. 7F). This evidence concerns the gene IGHE and Alzheimer disease.